142 related articles for article (PubMed ID: 38774475)
1. Measuring the Influence of Side Effect Expectations, Beliefs, and Incident Side Effects on the Risk for Drug Discontinuation Among Individuals Starting New Medications, a Cross-sectional Study.
Blackburn DF; Yao S; Taylor JG; Alefan Q; Lix LM; Eurich DT; Choudhry NK
Patient Prefer Adherence; 2024; 18():979-989. PubMed ID: 38774475
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with early nonpersistence among patients experiencing side effects from a new medication.
Alefan Q; Yao S; Taylor JG; Lix LM; Eurich D; Choudhry N; Blackburn DF
J Am Pharm Assoc (2003); 2022; 62(3):717-726.e5. PubMed ID: 34980560
[TBL] [Abstract][Full Text] [Related]
3. Comparing adherence and persistence across 6 chronic medication classes.
Yeaw J; Benner JS; Walt JG; Sian S; Smith DB
J Manag Care Pharm; 2009; 15(9):728-40. PubMed ID: 19954264
[TBL] [Abstract][Full Text] [Related]
4. Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis.
Yen L; Wu J; Hodgkins PL; Cohen RD; Nichol MB
J Manag Care Pharm; 2012; 18(9):701-12. PubMed ID: 23206213
[TBL] [Abstract][Full Text] [Related]
5. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study.
Lummis HL; Sketris IS; Gubitz GJ; Joffres MR; Flowerdew GJ
BMC Neurol; 2008 Jul; 8():25. PubMed ID: 18616796
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs.
Lunghi C; Moisan J; Grégoire JP; Guénette L
Value Health; 2017 Jun; 20(6):728-735. PubMed ID: 28577689
[TBL] [Abstract][Full Text] [Related]
8. Modifiable Factors Associated with Non-adherence to Antihypertensive or Antihyperlipidemic Drugs Are Dissimilar: a Multicenter Study Among Patients with Diabetes in Indonesia.
Alfian SD; Annisa N; Fajriansyah F; Perwitasari DA; Abdulah R; Hak E; Denig P
J Gen Intern Med; 2020 Oct; 35(10):2897-2906. PubMed ID: 32301043
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive Medication Nonpersistence and Low Adherence for Adults <65 Years Initiating Treatment in 2007-2014.
Tajeu GS; Kent ST; Huang L; Bress AP; Cuffee Y; Halpern MT; Kronish IM; Krousel-Wood M; Mefford MT; Shimbo D; Muntner P
Hypertension; 2019 Jul; 74(1):35-46. PubMed ID: 31132956
[TBL] [Abstract][Full Text] [Related]
10. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
11. Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication.
Tamblyn R; Abrahamowicz M; Dauphinee D; Wenghofer E; Jacques A; Klass D; Smee S; Eguale T; Winslade N; Girard N; Bartman I; Buckeridge DL; Hanley JA
Arch Intern Med; 2010 Jun; 170(12):1064-72. PubMed ID: 20585073
[TBL] [Abstract][Full Text] [Related]
12. Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden.
Rajpura J; Nayak R
J Manag Care Pharm; 2014 Jan; 20(1):58-65. PubMed ID: 24511766
[TBL] [Abstract][Full Text] [Related]
13. Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case-control study in patients with schizophrenia.
Ishak KJ; Tan Y; Glass J; Luong D; Caro JJ
Clin Ther; 2008 Jul; 30(7):1251-63. PubMed ID: 18691984
[TBL] [Abstract][Full Text] [Related]
14. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
[TBL] [Abstract][Full Text] [Related]
15. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
[TBL] [Abstract][Full Text] [Related]
16. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.
McHorney CA; Schousboe JT; Cline RR; Weiss TW
Curr Med Res Opin; 2007 Dec; 23(12):3137-52. PubMed ID: 17988435
[TBL] [Abstract][Full Text] [Related]
17. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
18. Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US™.
Wade SW; Satram-Hoang S; Stolshek BS
Osteoporos Int; 2014 Sep; 25(9):2279-90. PubMed ID: 24942502
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]